Literature DB >> 11264395

Suboptimal nucleotides in the infectious, pathogenic simian immunodeficiency virus clone SIVmac239.

L Alexander1, L Denekamp, S Czajak, R C Desrosiers.   

Abstract

We analyzed virus sequences in two monkeys infected with SIVmac239 and two monkeys infected with SHIVnef that maintained high, persisting viral loads. Sequence changes were observed consistently at four loci in all four animals: a single nucleotide change in the Lys-tRNA primer binding site in the 5' long terminal repeat; two nucleotide changes that resulted in two amino acid changes in the pol gene product; and a single nucleotide change in the region of the simian immunodeficiency virus genome where the rev and env genes overlap, resulting in changes in the predicted amino acid sequences of both gene products. None of these mutations were seen in short-term cultures of CEMx174 cells infected with SIVmac239 or SHIVnef. At all four positions in all four animals, the new sequences represented consensus sequences for primate lentiviruses, whereas the inoculum sequences at these four loci have either never been or rarely been reported outside of SIVmac239. Thus, although cloned SIVmac239 is consistently pathogenic and consistently induces high viral load set points, it is clearly less than optimal at these four nucleotide positions.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11264395      PMCID: PMC114897          DOI: 10.1128/JVI.75.8.4019-4022.2001

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  25 in total

1.  Pathogenesis of simian immunodeficiency virus encephalitis: viral determinants of neurovirulence.

Authors:  J L Mankowski; M T Flaherty; J P Spelman; D A Hauer; P J Didier; A M Amedee; M Murphey-Corb; L M Kirstein; A Muñoz; J E Clements; M C Zink
Journal:  J Virol       Date:  1997-08       Impact factor: 5.103

2.  A mutation in integrase can compensate for mutations in the simian immunodeficiency virus att site.

Authors:  Z Du; P O Ilyinskii; K Lally; R C Desrosiers; A Engelman
Journal:  J Virol       Date:  1997-11       Impact factor: 5.103

3.  A role for carbohydrates in immune evasion in AIDS.

Authors:  J N Reitter; R E Means; R C Desrosiers
Journal:  Nat Med       Date:  1998-06       Impact factor: 53.440

4.  Rhesus macaques previously infected with simian/human immunodeficiency virus are protected from vaginal challenge with pathogenic SIVmac239.

Authors:  C J Miller; M B McChesney; X Lü; P J Dailey; C Chutkowski; D Lu; P Brosio; B Roberts; Y Lu
Journal:  J Virol       Date:  1997-03       Impact factor: 5.103

5.  Plasma SIV RNA viral load determination by real-time quantification of product generation in reverse transcriptase-polymerase chain reaction.

Authors:  K Suryanarayana; T A Wiltrout; G M Vasquez; V M Hirsch; J D Lifson
Journal:  AIDS Res Hum Retroviruses       Date:  1998-01-20       Impact factor: 2.205

6.  Identification of a nef allele that causes lymphocyte activation and acute disease in macaque monkeys.

Authors:  Z Du; S M Lang; V G Sasseville; A A Lackner; P O Ilyinskii; M D Daniel; J U Jung; R C Desrosiers
Journal:  Cell       Date:  1995-08-25       Impact factor: 41.582

7.  Induction of AIDS in rhesus monkeys by a recombinant simian immunodeficiency virus expressing nef of human immunodeficiency virus type 1.

Authors:  L Alexander; Z Du; A Y Howe; S Czajak; R C Desrosiers
Journal:  J Virol       Date:  1999-07       Impact factor: 5.103

8.  Identification of highly attenuated mutants of simian immunodeficiency virus.

Authors:  R C Desrosiers; J D Lifson; J S Gibbs; S C Czajak; A Y Howe; L O Arthur; R P Johnson
Journal:  J Virol       Date:  1998-02       Impact factor: 5.103

9.  Vaccine protection by a triple deletion mutant of simian immunodeficiency virus.

Authors:  M S Wyand; K H Manson; M Garcia-Moll; D Montefiori; R C Desrosiers
Journal:  J Virol       Date:  1996-06       Impact factor: 5.103

10.  Diverse host responses and outcomes following simian immunodeficiency virus SIVmac239 infection in sooty mangabeys and rhesus macaques.

Authors:  A Kaur; R M Grant; R E Means; H McClure; M Feinberg; R P Johnson
Journal:  J Virol       Date:  1998-12       Impact factor: 5.103

View more
  23 in total

1.  Involvement of multiple epitope-specific cytotoxic T-lymphocyte responses in vaccine-based control of simian immunodeficiency virus replication in rhesus macaques.

Authors:  Miki Kawada; Hiroko Igarashi; Akiko Takeda; Tetsuo Tsukamoto; Hiroyuki Yamamoto; Sachi Dohki; Masafumi Takiguchi; Tetsuro Matano
Journal:  J Virol       Date:  2006-02       Impact factor: 5.103

2.  Potent antibody-mediated neutralization and evolution of antigenic escape variants of simian immunodeficiency virus strain SIVmac239 in vivo.

Authors:  Shuji Sato; Eloisa Yuste; William A Lauer; Eun Hyuk Chang; Jennifer S Morgan; Jacqueline G Bixby; Jeffrey D Lifson; Ronald C Desrosiers; Welkin E Johnson
Journal:  J Virol       Date:  2008-07-30       Impact factor: 5.103

3.  Adaptation of an R5 Simian-Human Immunodeficiency Virus Encoding an HIV Clade A Envelope with or without Ablation of Adaptive Host Immunity: Differential Selection of Viral Mutants.

Authors:  Mingkui Zhou; Michael Humbert; Muhammad M Mukhtar; Hanna B Scinto; Hemant K Vyas; Samir K Lakhashe; Siddappa N Byrareddy; Gregor Maurer; Swati Thorat; Joshua Owuor; Zhao Lai; Yidong Chen; Anthony Griffiths; Agnès-Laurence Chenine; Sanjeev Gumber; François Villinger; David Montefiori; Ruth M Ruprecht
Journal:  J Virol       Date:  2019-04-17       Impact factor: 5.103

4.  Importance of B-cell responses for immunological control of variant strains of simian immunodeficiency virus.

Authors:  Welkin E Johnson; Jeffrey D Lifson; Sabine M Lang; R Paul Johnson; Ronald C Desrosiers
Journal:  J Virol       Date:  2003-01       Impact factor: 5.103

5.  Genetically barcoded SIV reveals the emergence of escape mutations in multiple viral lineages during immune escape.

Authors:  Taina T Immonen; Celine Camus; Carolyn Reid; Christine M Fennessey; Gregory Q Del Prete; Miles P Davenport; Jeffrey D Lifson; Brandon F Keele
Journal:  Proc Natl Acad Sci U S A       Date:  2019-12-16       Impact factor: 11.205

6.  A nucleotide substitution in the tRNA(Lys) primer binding site dramatically increases replication of recombinant simian immunodeficiency virus containing a human immunodeficiency virus type 1 reverse transcriptase.

Authors:  Kelly Soderberg; Lynn Denekamp; Sarah Nikiforow; Karen Sautter; Ronald C Desrosiers; Louis Alexander
Journal:  J Virol       Date:  2002-06       Impact factor: 5.103

7.  Glycosylation of simian immunodeficiency virus influences immune-tissue targeting during primary infection, leading to immunodeficiency or viral control.

Authors:  Chie Sugimoto; Shinichiro Nakamura; Shoko I Hagen; Yasuko Tsunetsugu-Yokota; Francois Villinger; Aftab A Ansari; Yasuo Suzuki; Naoki Yamamoto; Yoshiyuki Nagai; Louis J Picker; Kazuyasu Mori
Journal:  J Virol       Date:  2012-06-20       Impact factor: 5.103

8.  Envelope-modified single-cycle simian immunodeficiency virus selectively enhances antibody responses and partially protects against repeated, low-dose vaginal challenge.

Authors:  Michael D Alpert; Andrew R Rahmberg; William Neidermyer; Sharon K Ng; Angela Carville; Jeremy V Camp; Robert L Wilson; Michael Piatak; Keith G Mansfield; Wenjun Li; Christopher J Miller; Jeffrey D Lifson; Pamela A Kozlowski; David T Evans
Journal:  J Virol       Date:  2010-08-11       Impact factor: 5.103

9.  In Vivo Validation of the Viral Barcoding of Simian Immunodeficiency Virus SIVmac239 and the Development of New Barcoded SIV and Subtype B and C Simian-Human Immunodeficiency Viruses.

Authors:  Sirish Khanal; Christine M Fennessey; Sean P O'Brien; Abigail Thorpe; Carolyn Reid; Taina T Immonen; Rodman Smith; Julian W Bess; Adrienne E Swanstrom; Gregory Q Del Prete; Miles P Davenport; Afam A Okoye; Louis J Picker; Jeffrey D Lifson; Brandon F Keele
Journal:  J Virol       Date:  2019-12-12       Impact factor: 5.103

10.  Biphasic CD8+ T-Cell Defense in Simian Immunodeficiency Virus Control by Acute-Phase Passive Neutralizing Antibody Immunization.

Authors:  Sumire Iseda; Naofumi Takahashi; Hugo Poplimont; Takushi Nomura; Sayuri Seki; Taku Nakane; Midori Nakamura; Shoi Shi; Hiroshi Ishii; Shota Furukawa; Shigeyoshi Harada; Taeko K Naruse; Akinori Kimura; Tetsuro Matano; Hiroyuki Yamamoto
Journal:  J Virol       Date:  2016-06-24       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.